He presented the CVID immunophenotype, accompanied by a significant decrease in CD19+CD5+ B cells (26/μL, normal range: 175–332/μL) and CD4+ T cells (272/μL, normal range: 471–1220/μL). This evidence concerns the gene CD19 and common variable immunodeficiency.